Understanding C Difficile Infections

December 6, 2021
Kenny Walter

Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

The State of the Science events allows experts to come together to update on recent research for CDI.

It is an interesting and important time for clostridium difficile infection (CDI) research, as the spread may be increasing, but new microbiome live therapeutics may be soon on the horizon.

With research and our understanding on the infectious disease changing almost daily it is important for investigators, doctors, and stakeholders to come together to share knowledge and theories whenever possible.

Recently, Teena Chopra, MD, MPH, Wayne State University, headlined HCPLive’s State of Science Program called Institutional Perspectives in Infectious Diseases: Management of C. Difficile.

Chopra was joined by Ammara Mushtaq, MD, Wayne State University, Bhagyashri Navalkele, MD, UMMC, and Avnish Sandhu, DO, Wayne State University.

The discussion included presentations on understanding C difficile infections, standards of care, emerging treatments, and an update on managing the disease.